Use of an Intraperitoneal Ventricular Assist Device With a Polytetrafluoroethylene Barrier Decreases Infections

Journal of Heart and Lung Transplantation

Volumn 27, Issue 3, 2008, Pages 268-271

  Holman, William L ^a   Pamboukian, Salpy V ^b   Bellot, S Chris ^a   Blood, Peggy S ^c   Tallaj, Jose A ^b   Sharpton, Jessica L ^c   Kirklin, James K ^a  

^a Kentucky   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; POLITEF;

ADULT; ANASTOMOSIS DEHISCENCE; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DEVICE INFECTION; DRUG IMPLANT; ENTEROCOCCUS; EQUIPMENT DESIGN; HEART ASSIST DEVICE; HUMAN; INFECTION PREVENTION; INFECTION RATE; INTERMETHOD COMPARISON; INTRAPERITONEUM VENTRICLE ASSIST DEVICE; MAJOR CLINICAL STUDY; PATIENT SELECTION; PERITONITIS; POLITEF IMPLANT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCUS; VISCERA;

AGED; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEART-ASSIST DEVICES; HUMANS; MIDDLE AGED; PERITONEAL CAVITY; POLYTETRAFLUOROETHYLENE; PREVALENCE; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 40649108324     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.12.004     Document Type: Article

References (12)

1. Institute of Medicine. The artificial heart: prototypes, policies, and patients (1991), National Academy Press, Washington, DC
2. el-Banayosy A., Arusolglu L., Kizner L., et al. Preliminary experience with the LionHeart left ventricular assist device in patients with end-stage heart failure. Ann Thorac Surg 75 (2003) 1469-1475
3. Pae W.E., Connell J.M., Adelowo A., et al. Does total implantability reduce infection with the use of a left ventricular assist device?. The LionHeart experience in Europe. J Heart Lung Transplant 26 (2007) 219-229
4. Wasler A., Springer W.E., Radovancevic B., et al. A comparison between intraperitoneal and extraperitoneal left ventricular assist system placement. ASAIO J 42 (1996) M573-M576
5. McCarthy P.M., Wang N., and Vargo R. Preperitoneal insertion of the HeartMate 1000 IP implantable left ventricular assist device. Ann Thorac Surg 57 (1994) 634-638
6. Phillips W.S., Burton N.A., Macmanus Q., and Lefrak E.A. Surgical complications in bridging to transplantation: the Thermo Cardiosystems LVAD. Ann Thorac Surg 53 (1992) 482-486
7. Icenogle T., Sandler D., Puhlman M., et al. Intraperitoneal pocket for left ventricular assist device placement. J Heart Lung Transplant 22 (2003) 818-821
8. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
9. Holman W.L., Park S.J., Long J.W., et al. Infection in permanent circulatory support: experience from the REMATCH Trial. J Heart Lung Transplant 23 (2003) 1359-1365
10. McKellar S.H., Allred B.D., Marks J.D., et al. LVAD pocket infection controlled with antibiotic-impregnated polymethylmethacrylate beads. Ann Thorac Surg 67 (1999) 554-555
11. Costerton J.W., Stewart P.S., and Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 284 (1999) 1318-1322
12. Fux C.A., Costerton J.W., Stewart P.S., and Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol 13 (2005) 34-40